kezarlifesciences.com (KZR) - Final Profit

KZR (Kezar Life Sciences Inc.) - company brandmark

Demand for innovative autoimmune pathology therapies remains independent of market cycles, as evidenced by the consolidated profit of Kezar Life Sciences (KZR). However, the battle for sector leadership has intensified due to drug side effects, and the -0.04 metric indicates the status of current yields. Risks are linked to high trial uncertainty, patent disputes, and an intensive cash burn rate.

KZR Kezar Life Sciences Company Net Income (07/04/2022 - 05/23/2026)
Core merchandise of Kezar Life Sciences, Inc.

Net income reflects the final efficiency of capital generation after deducting all operating and tax expenses, determining the fundamental value of the business. By analyzing the net income trend of Kezar Life Sciences (KZR), an investor assesses the speed of asset capitalization, which for Kezar Life Sciences directly correlates with the costs of complying with strict bioethical standards and the environmental optimization of biotechnological laboratories.

Direct competitors

argenx BVBA (ARGX) - Net Profit|Net Income BNTX|ABVX: Final Profit|Net Profit ADMA|Net Financial Result Protagonist Therapeutics, Inc.|Company Net Income Immunovant Corp IMVT|KNSA - Net Income|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|CLDX (Celldex Therapeutics, Inc.) - Net Income|Aurinia Pharmaceuticals Inc (AUPH) - Net Profit|Company Net Income BioCryst Pharmaceuticals Inc|Company Profit VERA (Vera Corp)|Net Profit DNTH|PHVS - Company Net Income|Company Net Income AbCellera Biologics Inc ABCL|Net Profit Tourmaline Bio Inc TRML|Intrexon - Net Profit|Company Net Income Pharming Corp|NKTR (Nektar Therapeutics) - Net Income|Profit After Tax UPB (upstreambio.com)|ZBIO (Zenas Biopharma) - Net Profit|Net Profit Immunome Inc|Company Net Income Gossamer Corp (GOSS)|KALV (KalVista Corp) - Final Profit|Septerna Inc - Net Income|Final Profit PVLA|SVRA - Company Net Income|RIGL: Company Net Income|ANAB: Net Profit|ATXS - Net Financial Result|ENGN (enGene Holdings Inc.) - Net Profit|rapt.com - Profit After Tax|Net Profit JBIO|ACRS - Company Net Income|Kyverna - Net Income|Final Profit TLSA|CABA - Company Net Income|Net Financial Result ventyxbio.com VTYX|THTX: Net Profit|Net Income Avalo Therapeutics, Inc.|ELDN (Eledon) - Net Profit|Agenus, Inc (AGEN) - Net Financial Result|Net Profit CLYM|ZURA - Company Net Income|Company Net Income aTyr Pharma ATYR|ADAG: Company Profit|Ikena Oncology, Inc. - Net Profit|Shattuck Labs, Inc. (STTK) - Net Income|EQ: Net Profit|Company Net Income Connect Biopharma Holdings Limited (CNTB)|Company Net Income Immunic Therapeutics|Atara Biotherapeutics Inc (ATRA) - Net Financial Result|Company Net Income InflaRx N.V. (IFRX)|Net Profit X4 Pharmaceuticals, Inc (XFOR)|Adicet Bio, Inc. - Net Income|CELU (Celularity Inc) - Profit After Tax|INMB - Company Net Income|Final Profit BRNS (Barinthus Biotherapeutics PLC)|SAB Biotherapeutics, Inc (SABS) - Company Net Income|Profit After Tax AKTX (Akari Therapeutics, Plc)|ENLV (Enlivex Therapeutics Ltd) - Net Profit|QTTB: Final Profit|Net Profit GOVX|Net Profit Edesa Biotech Inc (EDSA)|Company Net Income iBio Corp IBIO|Final Profit CARM|XTLB - Company Net Income|Bolt Biotherapeutics (BOLT) - Net Income|HCWB: Net Profit|Aptevo Therapeutics Inc. (APVO) - Net Profit|Net Income AIM|ADTX: Final Profit|Net Profit GRI|Net Financial Result xortx.com|Company Net Income Vyome Holdings HIND|REVB - Net Income|INDP - Company Net Income|BiondVax Pharmaceuticals (SCNI) - Net Income|CALI (calcimedica.com) - Net Income|Affimed N.V. (AFMD) - Net Profit|Company Net Income Allakos Inc|Company Profit HOOK (HOOKIPA)|Net Profit IGMS|ITOS - Company Net Income|Company Net Income Ocean Biomedical, Inc. OCEA|Net Profit tcbiopharm.com TCBP|Third Harmonic Bio, Inc. - Net Profit